
Sign up to save your podcasts
Or
How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_mscpedu
4
77 ratings
How can you optimize the treatment pathway for relapsed or refractory chronic lymphocytic leukemia (CLL)? Join the experts as they delve into the latest updates from EHA 2024. Credit available for this activity expires: 07/31/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001409 ?ecd=bdc_podcast_libsyn_mscpedu
131 Listeners
13 Listeners
322 Listeners
853 Listeners
480 Listeners
690 Listeners
16 Listeners
274 Listeners
251 Listeners
3,314 Listeners
250 Listeners
90 Listeners
1,084 Listeners
175 Listeners
507 Listeners
316 Listeners
58 Listeners
23 Listeners
270 Listeners